Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 janv. 2019 16h15 HE | Source: MRI Interventions, Inc.

MRI Interventions Announces Estimated 30% Growth Driven by Record Revenue and Record ClearPoint® Procedure Volume in 2018 Fourth Quarter

IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures for deep brain...
03 janv. 2019 16h05 HE | Source: MRI Interventions, Inc.

MRI Interventions Receives FDA Clearance for ClearPoint® PURSUIT™ Neuro Aspiration System

IRVINE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation in procedures involving deep-brain...
10 déc. 2018 16h42 HE | Source: MRI Interventions, Inc.

MRI Interventions Congratulates Voyager Therapeutics on First Patient Dosing in RESTORE-1, the Phase 2 VY-AADC Gene Therapy Trial for Parkinson’s Disease

IRVINE, Calif. , Dec. 10, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC), a platform neurosurgery company with products designed for navigation, ablation and gene therapy, today...
12 nov. 2018 16h05 HE | Source: MRI Interventions, Inc.

MRI Interventions Reports Record ClearPoint® Cases and Disposable Functional Neurosurgery Revenue in Third Quarter

IRVINE, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB: MRIC) (the “Company”) today announced financial results for its third fiscal quarter ended September 30, 2018. ...
06 nov. 2018 16h11 HE | Source: MRI Interventions, Inc.

MRI Interventions Announces FDA Clearance of ClearPoint® 2.0 Next-Generation Software Platform

Initial Limited Market Release Shipments to Commence Immediately IRVINE, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced FDA clearance for the...
05 nov. 2018 16h05 HE | Source: MRI Interventions, Inc.

MRI Interventions, Inc. to Announce Third Quarter 2018 Results on November 12

IRVINE, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) announced that it will release financial results for its 2018 third quarter, which ended September 30, 2018, on...
25 oct. 2018 16h05 HE | Source: MRI Interventions, Inc.

MRI Interventions Congratulates Axovant on First Patient Dosing in New Gene Therapy Clinical Study for Patients with Parkinson’s Disease

Initial Data Expected in First Half of 2019 IRVINE, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Axovant Sciences Ltd. on the dosing of its first patient...
24 oct. 2018 16h05 HE | Source: MRI Interventions, Inc.

MRI Interventions Congratulates Monteris Medical on FDA Clearance of NeuroBlate Laser Probe

IRVINE, Calif., Oct. 24, 2018 (GLOBE NEWSWIRE) -- MRI Interventions (OTCQB:MRIC) congratulates Monteris Medical on the FDA Clearance of its new NeuroBlate Optic Laser Probe. The new probe replaces a...
19 oct. 2018 07h30 HE | Source: MRI Interventions, Inc.

MRI Interventions Signs Exclusive Distribution Agreement with Clinical Laserthermia Systems (CLS) for U.S. and Canada

Agreement Enables MRI Interventions to Distribute CLS’s Precision Ablation Product Portfolio for Use in Interventional MR-Guided Procedures Beyond Previously Announced Spine and Neuro License...
17 oct. 2018 10h24 HE | Source: MRI Interventions, Inc.; Clinical Laserthermia Systems AB

MRI Interventions and Clinical Laserthermia Systems (CLS) Announce Collaboration to Develop Next-Generation Navigation and Laser Ablation Platforms for Neurosurgery -- UPDATE

Under the terms of the agreement, MRIC acquires worldwide exclusive rights to the platform for use in Neurosurgery and Spine with CLS as manufacturer IRVINE, Calif. and LUND, Sweden, Oct. 17, 2018 ...

Page précédente

Page suivante